Logotipo do repositório
 

Publicação:
Systemic immunotoxicity reactions induced by adjuvanted vaccines

dc.contributor.authorBatista-Duharte, Alexander [UNESP]
dc.contributor.authorPortuondo, Deivys [UNESP]
dc.contributor.authorPerez, O.
dc.contributor.authorCarlos, Iracilda Zeppone [UNESP]
dc.contributor.institutionMed Sci Univ
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionCAPES PVE Brasil Grant
dc.contributor.institutionUniv Med Sci Havana
dc.date.accessioned2014-12-03T13:09:12Z
dc.date.available2014-12-03T13:09:12Z
dc.date.issued2014-05-01
dc.description.abstractVaccine safety is a topic of concern for the treated individual, the family, the health care personnel, and the others involved in vaccination programs as recipients or providers. Adjuvants are necessary components to warrant the efficacy of vaccines, however the overstimulation of the immune system is also associated with adverse effects. Local reactions are the most frequent manifestation of toxicity induced by adjuvanted vaccines and, with the exception of the acute phase response (APR), much less is known about the systemic reactions that follow vaccination. Their low frequency or subclinical expression meant that this matter has been neglected. In this review, various systemic reactions associated with immune stimulation will be addressed, including: APR, hypersensitivity, induction or worsening of autoimmune diseases, modification of hepatic metabolism and vascular leak syndrome (VLS), with an emphasis on the mechanism involved. Finally, the authors analyze the current focus of discussion about vaccine safety and opportunities to improve the design of new adjuvanted vaccines in the future. (C) 2014 Elsevier B.V. All rights reserved.en
dc.description.affiliationMed Sci Univ, Toxicol & Biomed Ctr TOXIMED, Immunotoxicol Lab, Santiago De Cuba 90400, Cuba
dc.description.affiliationUniv Estadual Paulista, UNESP, Fac Pharmaceut Sci, BR-14801902 Araraquara, SP, Brazil
dc.description.affiliationCAPES PVE Brasil Grant, Foreigner Visiting Prof Program, Araraquara, Brazil
dc.description.affiliationUniv Med Sci Havana, Inst Preclin & Basic Sci ICBP Victoria de Giron, Dept Immunol, Havana, Cuba
dc.description.affiliationUnespUniv Estadual Paulista, UNESP, Fac Pharmaceut Sci, BR-14801902 Araraquara, SP, Brazil
dc.description.sponsorshipUNESP
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.format.extent170-180
dc.identifierhttp://dx.doi.org/10.1016/j.intimp.2014.02.033
dc.identifier.citationInternational Immunopharmacology. Amsterdam: Elsevier Science Bv, v. 20, n. 1, p. 170-180, 2014.
dc.identifier.doi10.1016/j.intimp.2014.02.033
dc.identifier.issn1567-5769
dc.identifier.lattes1730146818754269
dc.identifier.urihttp://hdl.handle.net/11449/112063
dc.identifier.wosWOS:000336337900023
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Immunopharmacology
dc.relation.ispartofjcr3.118
dc.relation.ispartofsjr1,051
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectSystemic reactionsen
dc.subjectAdjuvanten
dc.subjectVaccineen
dc.subjectImmunotoxicityen
dc.subjectAction mechanismsen
dc.titleSystemic immunotoxicity reactions induced by adjuvanted vaccinesen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isDepartmentOfPublicationa83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isDepartmentOfPublication.latestForDiscoverya83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes1730146818754269
unesp.author.orcid0000-0002-0084-3468[4]
unesp.author.orcid0000-0002-1875-0518[1]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentAnálises Clínicas - FCFpt

Arquivos